Engineering disease analyte response in peptide self-assembly.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Chemical Biology

Background:

• Therapeutic nanocarriers require enhanced precision and specificity for effective disease treatment.
• Self-assembled peptides present a versatile platform for creating precisely defined nanoscale materials.
• Disease states are often indicated by specific small molecules (e.g., pH, H2O2, glucose) and biomolecules.

Purpose of the Study:

• To review the design and construction of therapeutic nanocarriers using self-assembled peptides.
• To explore how peptide engineering and non-peptidic components can link nanocarrier assembly to disease cues.
• To highlight the potential of peptide-based nanocarriers for targeted therapy.

Main Methods:

• Peptide sequence engineering for tailored self-assembly.
• Incorporation of non-peptidic components to modulate nanocarrier properties.
• Investigating peptide responses to disease-relevant small molecules (pH, redox, glucose).

Main Results:

• Self-assembled peptides can be designed to alter solubility, electrostatic interactions, or undergo chemical transformations in response to disease cues.
• Peptide nanocarrier assembly state can be dynamically linked to the presence of specific small molecules.
• Engineered peptide sequences and added components enable precise control over nanocarrier behavior.

Conclusions:

• Self-assembled peptides offer a tunable platform for developing smart therapeutic nanocarriers.
• Linking nanocarrier assembly to disease biomarkers enhances targeting and specificity.
• This approach holds significant promise for advancing precision medicine and drug delivery systems.